WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009143150) INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/143150    International Application No.:    PCT/US2009/044511
Publication Date: 26.11.2009 International Filing Date: 19.05.2009
IPC:
C07D 417/00 (2006.01)
Applicants: BURNHAM INSTITUTE FOR MEDICAL RESEARCH; 10901 North Torrey Pines Road La Jolla, CA 92037 (US) (For All Designated States Except US).
MILLAN, Jose, Luis [US/US]; (US) (For US Only).
NARISAWA, Sonoko [JP/US]; (US) (For US Only).
SERGIENKO, Eduard [RU/US]; (US) (For US Only)
Inventors: MILLAN, Jose, Luis; (US).
NARISAWA, Sonoko; (US).
SERGIENKO, Eduard; (US)
Agent: HUIZENGA, David, E.; (US)
Priority Data:
61/054,326 19.05.2008 US
Title (EN) INTESTINAL ALKALINE PHOSPHATASE MODULATORS AND USES THEREOF
(FR) MODULATEURS DE LA PHOSPHATASE ALCALINE INTESTINALE ET LEURS UTILISATIONS
Abstract: front page image
(EN)Disclosed are modulators, i.e., activators and inhibitors, of Intestinal Alkaline Phosphatase (IAP). Also disclosed are methods for treating bacterial infections of the intestinal tract and methods for maintaining the health of the intestinal tract using IAP activators. Further disclosed are methods to assist in weight gain of emaciated patients and those having reduced or negligible fat absorption using IAP inhibitors.
(FR)L'invention porte sur des modulateurs, à savoir des activateurs et des inhibiteurs de la phosphatase alcaline intestinale (IAP). L'invention porte également sur des procédés de traitement des infections bactériennes du tractus intestinal et sur des procédés pour maintenir la santé du tractus intestinal à l'aide d'activateurs d'IAP. L'invention porte en outre sur des procédés pour aider au gain de poids de patients émaciés et de ceux ayant une absorption de graisses réduite ou négligeable à l'aide d'inhibiteurs d'IAP.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)